AKAkira Katsuyama

Akira Katsuyama

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Akira Katsuyama has a total of 98 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Molecular basis of coupled peptidoglycan synthesis by the FtsWIQLB divisome complex from Vibrio cholerae

    by Aili Hao, Ryotaro Okawa, Akira Katsuyama, Satoshi Ichikawa, Seok-Yong Lee

  • An N ‐acyl Donor for Serine/Threonine Ligation Involving a Direct N ‐to‐ N Acyl Shift

    by Takafumi Iwasaki, Rintaro Kaguchi, Toyotaka Sato, Satoshi Takahashi, Motohiro Horiuchi, Shin‐Ichi Yokota, Satoshi Ichikawa, Akira Katsuyama

    Developing precise peptide modification protocols is crucial for peptide‐based drug development. While chemical ligation addresses this, conventional methods often face difficulties such as side reactions due to the high electrophilicity of S ‐ or O ‐acyl donors. Here we developed an N ‐(2‐formylphenyl)‐hydroxamate (HDX) ester as an N ‐acyl donor for chemical ligation involving a direct N ‐to‐ N acyl shift, eliminating the need for S ‐ or O ‐acyl compounds. Mechanistic studies revealed kinetic selectivity between substrates and the reversibility of the acyl shift, suggesting the possibility achieving chemoselectivity through kinetic and thermodynamic control. In addition, an HDX ester was applied to the structural modification of polymyxin derivatives, demonstrating that HDX esters can be useful for the modification of complex peptides. These findings provide a blueprint for designing N ‐acyl donors for chemical ligation, accelerating the advancement of peptide‐based therapeutics.

  • Open Access

    Manipulation of Conformational Changes in Cyclic Peptides Using a Molecular Switch

    by Taichi Akahane, Satoshi Ichikawa, Akira Katsuyama

    Compared to linear peptides, cyclic peptides have attracted much attention because of enhanced binding affinity, membrane permeability, and metabolic stability through constrained conformations. Recent studies revealed that some cyclic peptides can adopt multiple conformers, influencing their biological activity. However, strategies to control these interconversions remain underexplored. In this study, we introduced an ortho ‐disubstituted benzamide (DiBA) unit as a molecular switch in cyclic peptides, enabling the separation of conformers and selective interconversion between four conformers. The DiBA unit has C─N and C─C bonds that can be controlled by external stimuli. The method was successfully applied to cyclic peptides with different ring sizes and amino acid sequences, and selective interconversion between conformations was achieved by different stimuli such as light and heat. These results suggest that regulating biological activity through the controlled interconversion between multiple conformations of a cyclic peptide may be applicable as a method for modulating its biological activity.

  • Open Access

    Sparfloxacin reveals a host–virus dual-target antiviral scaffold against respiratory syncytial virus

    by Yuka Takumi-Tanimukai, Soh Yamamoto, Yurie Yoshida, Tatsuki Takahashi, Akira Takasawa, Akira Katsuyama, Takumi Nishimaki, Haruka Maeda, Katsumi Mizuta, Masashi Idogawa, et al.

    Respiratory syncytial virus (RSV) is a major cause of severe respiratory illness across the lifespan, particularly in infants and older adults. Nonetheless, effective antiviral therapies remain limited. Here, we performed a clinically guided, medium-throughput screening of approved drugs used in pediatric populations and identified sparfloxacin (SPFX), a fluoroquinolone antibiotic, as a mechanistically informative antiviral scaffold. SPFX showed antiviral activity against genetically distinct RSV clinical isolates in vitro, and suppressed RSV infection in a mechanistic mouse model in vivo. Mechanistically, our findings support a host–virus dual-target framework in which SPFX suppresses RSV replication through activity consistent with modulation of viral RNA polymerase function together with a pro-viral HSP70-associated host pathway. Using primary human pediatric airway epithelial cells, we identified SPFX-responsive host factors and observed suppression of HSP70 expression independent of infection. Together, these findings establish SPFX as a mechanistically informative antiviral scaffold and support a host–virus dual-target framework for future RSV therapeutic development.

  • Asymmetric Total Synthesis of (+)-Acaulone B

    by Sho Fujii, Jun Hirabayashi, Akira Katsuyama, Satoshi Ichikawa, Fumika Yakushiji

    Acaulone B (1) was isolated from Acaulium sp. H-JQSF. The cyclohexenone moiety of 1 was constructed via late-stage chemo-, regio-, and stereoselective Diels-Alder reactions between a diene unit and the C8-C9 double bond of the 14-membered macrodiolide. The regioselectivity of the [4 + 2] cycloaddition was analyzed by DFT calculations, which showed the lowest Gibbs energy of the TS structure and asynchronous cycloaddition. Our investigation demonstrates the effectiveness of late-stage functionalization of macrocycles to synthesize complex natural products.

  • Total Synthesis, Antibacterial Activity, and Structural Analysis of Atratumycin and Its Analogues

    by Yuya Sawayama, Rintaro Kaguchi, Motoko Shinohara, Yusuke Minato, Satoshi Ichikawa, Akira Katsuyama

    Solid-phase total synthesis of atratumycin (1) and its analogues is described. The linear depsipeptide was synthesized by the standard Fmoc solid-phase peptide synthesis, on-resin esterification, and epimerization-free macrolactamization. A structure-activity relationship study of 1 led to the identification of the amino acid residue that preserves its antituberculosis activity. Conformational analyses of 1 and its analogues revealed that the solution structure of 1 closely resembles the crystal structure of 1, suggesting the structural rigidity of its unique conformation.

  • Open Access

    Optimization of galectin-3 binding agents by in situ multiple compound synthesis and native mass spectrometry

    by Kazuki Hoshi, Tsuyoshi Konuma, Rina Taguchi, Satoko Akashi, Yoshiya Katahira, Akira Katsuyama, Satoshi Ichikawa

    Developing high-affinity drug lead critically depends on the efficient structural optimization of a lead compound. However, the dynamic nature of the process by which drugs bind to target molecules often complicates the rational design of effective substituents, even if their three-dimensional structure is available. Herein, we report a streamlined strategy for the optimization of a galectin-3 binder through the integration of in situ chemistry and native mass spectrometry. This method involves the simultaneous synthesis of multiple analogues in a single reaction vessel, followed by the direct identification of high-affinity derivatives using native mass spectrometry. This approach enables the detection of ligand–protein complexes under native conditions. Through the further structural modification of the identified hit compound, we finally identified high-affinity galectin-3 binders. The results demonstrated that our strategy would reduce the time and effort required for the structural optimization stage of a lead compound.

  • Open Access

    Retrosynthetic Analysis-Aware Fragment Linking for Structure-Guided Ligand Extension

    by Akira Katsuyama, Yasuaki Tokodai, Kazuki Hoshi, Satoshi Ichikawa

    Synthetic accessibility is a key issue in the current compound generation. Unlike conventional approaches that assess synthetic accessibility after compound generation, the fragment-based method proposed in this study links the fragments in the reverse direction of the retrosynthesis analysis guaranteeing the synthetic accessibility. We developed a LigX, a Python module that incorporates this concept into the structure-based compound generation and applied it for the generation of nuclear receptor-binding SET domain-containing 2 (NSD2)-PWWP domain binders. The LigX generated structurally diverse compounds with higher synthetic accessibility. The effectiveness of our method was demonstrated through the chemical synthesis of one of the generated compounds, which showed a moderate binding affinity for recombinant NSD2. The results presented here suggest that by considering the difference between fragments suitable for compound generation and those used in chemical synthesis, it is possible to generate compounds with improved synthetic accessibility.

  • Open Access

    Non-ribosomal peptide cyclase-directed chemoenzymatic synthesis of lariat lipopeptides

    by Masakazu Kobayashi, Kenichi Matsuda, Yuito Yamada, Rintaro Ichihara, Naho Onozawa, Hanako Fukano, Yoshihiko Hoshino, Aki Hirabayashi, Masato Suzuki, Akira Katsuyama, et al.

    Lariat-shaped lipopeptides are important antimicrobial agents; however, their complex structures pose synthetic challenges that hamper efficient structural diversification. Here we report a new chemoenzymatic approach that facilitates access to lariat-shaped macrocycles. Unprotected, branched peptides bearing multiple nucleophiles, including a native amino terminus and a pseudo-amino terminus, were site-selectively cyclized using versatile non-ribosomal peptide cyclases, generating an array of lariat peptides with diverse sequences and ring sizes. The generality of this strategy was demonstrated using two penicillin-binding protein-type thioesterases, SurE and WolJ, as well as one type-I thioesterase, TycC thioesterase. Furthermore, the remaining nucleophile, which was not involved in the cyclization process, was exploited as a reactive handle for subsequent diversification via a site-selective acylation reaction (that is, Ser/Thr ligation). The tandem cyclization–acylation strategy enabled the one-pot, modular synthesis of lariat-shaped lipopeptides equipped with various acyl groups. Biological screening revealed that the site-selective acylation endowed the macrocyclic scaffolds with antimycobacterial activity and led to the identification of lipopeptides that inhibit 50% of growth at concentrations of 8–16 µg ml−1.


  • Open Access

    pH-Controlled isomerization kinetics of ortho-disubstituted benzamidines: E/Z isomerism and axial chirality

    by Ryota Kimura, Satoshi Ichikawa, Akira Katsuyama

    PH-Responsive molecular switches and motors are a class of organic molecules whose three-dimensional structure can be changed by acid–base stimuli. To date, pH-responsive molecular switches have been developed using various functional groups, but further advances require expanding the range of pH-responsive systems and discovering new molecular architectures. Here, we investigate the pH-responsive behavior of ortho-disubstituted benzamidine, which generates atropisomers and E/Z isomers. The amidine moiety allows modulation of the C–N and C–N/C–C rotational barriers by protonation, providing a novel approach to control the kinetics of isomerization via pH adjustment. The results showed that protonation of the amidine moiety significantly suppresses both C–N bond rotation and C–N/C–C concerted rotation, demonstrating the potential of ortho-disubstituted benzamidine derivatives as a novel pH-responsive molecular switch.